CVS Caremark, the US pharmacy retailer, is issuing the largest investment grade corporate bond so far this year after its contentious four-month merger battle.

The company is selling a $5.5bn (€4.01bn) bond offering to repay existing debt and to buy back stock according to Dow Jones, the owner of Financial News.